RNA - Avidity Biosciences Inc
Avidity Biosciences Inc Logo

RNA - Avidity Biosciences Inc

https://www.aviditybiosciences.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.

52W High
$56.00
52W Low
$21.51

MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.99
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-5.72
EV/Revenue (<3 favorable)
494.08
P/S (TTM) (<3 favorable)
603.87
P/B (<3 favorable)
5.43
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
4.79%
Institutions (25–75% balanced)
107.42%
Shares Outstanding
128,653,000
Float
98,337,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
10,729,000
Gross Profit (TTM)
-399,707,008
EPS (TTM)
-3.56
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-44.49%
ROE (TTM) (>15% strong)
-0.38%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.88
Momentum
Bearish momentum
Value
2.9761
Previous
2.8226
Trend
Rising
Signal Cross
No cross

As of
Sep. 05, 2025